Ebv-positive Dlbcl

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-03-30
Clinical Trial Update: Zanubrutinib Combined With Tislelizumab in the Treatment of r/r PMBCL and EBV+ DLBCL [Phase 2]
Phase 2 clinical trial evaluating zanubrutinib with tislelizumab for relapsed/refractory primary mediastinal large B-cell lymphoma and EBV-p…